Research ArticleConference Proceeding - Article
Viral Clearance by Traditional Operations with Significant Knowledge Gaps (Session II): Protein A Chromatography
Brian Hubbard
PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 13-16; DOI: https://doi.org/10.5731/pdajpst.2014.00961
Brian Hubbard
Amgen, Thousand Oaks, CA
Ph.D.References
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 68, Issue 1
January/February 2014
Viral Clearance by Traditional Operations with Significant Knowledge Gaps (Session II): Protein A Chromatography
Brian Hubbard
PDA Journal of Pharmaceutical Science and Technology Jan 2014, 68 (1) 13-16; DOI: 10.5731/pdajpst.2014.00961
Jump to section
- Article
- Background
- Impact of Process Parameters on Viral Clearance Results Achieved on Protein A–Based Affinity Step (Olga Galperina, David Kahn; Human Genome Sciences)
- Key Process Parameters for Removal of Model Retrovirus and Parvovirus by Agarose-Based Recombinant Protein A Affinity Chromatography (John Mattila; Regeneron Pharmaceuticals Inc.)
- Impact of Product on MuLV Removal by Protein A Chromatography (L. Connell-Crowley; Amgen)
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
- No related articles found.